Officials said the unlawful profits from the misbranded drugs were made through a York County business. York, PA - Four men, including one from York County, were indicted Thursday with allegedly being involved in a scam to distribute misbranded erectile dysfunction drugs through a York County business and concealing the profits, according to the United States Attorney's Office for the Middle District of Pennsylvania. Almuntasser "Alex" Hbaiu, 34, of Los Angeles was previously charged with criminal conspiracy, delivery of misbranded drugs, receipt of misbranded drugs and two counts of wire fraud. A grand jury returned a second superseding indictment on March 8 that charged Hbaiu with additional offenses of structuring financial transactions and bank fraud. The new indictment also charged three additional people. Ahed Hbaiu, 32, of Etters is charged with criminal conspiracy, delivery of misbranded Gil Conrad Dizon, 24, of Los Angeles and Christopher Mouzon, 27, also of Los Angeles, are facing charges, as well. The superseding indictment charges that the four men were involved with various companies that sold drugs including Mojo Nights, Libigrow and Blue Diamond -- all marketed as all-natural versions of sexual enhancement drugs, the release states. The drugs contained sildenafil and citrate, active ingredients … Continue reading →

Washington, Mar 16 (ANI): Transplantation of mesenchymal stem cells cultivated on the surface of nanofibrous meshes could be a novel therapeutic strategy against post-prostatectomy erectile dysfunction (ED), researchers have claimed. The study was conducted by a group of Korean scientists and will be awarded 3rd prize for best abstract in non-oncology research on the opening day of the congress. During their investigation, the group aimed to examine the differentiation of human mesenchymal stem cells cultivated on the surface of nanofibrous meshes (nano-hMSCs) into neuron-like cells and repair of erectile dysfunction using their transplantation around the injured cavernous nerve (CN) of rats. "The objectives of the study reflect a very pertinent need in today's urology practice," the lead author of the investigation Prof. Y.S. Song of Soonchunhyang University School of Medicine in South Korea said. "Post-prostatectomy erectile dysfunction results from injury to the cavernous nerve that provides the autonomic input to erectile tissue. It is a common complication after radical prostatectomy which decreases the patient's quality of life. "Although advances in equipment and surgical techniques reduce this complication, patients still experience erectile dysfunction after radical prostatectomy," he said. Treatment of phosphodiesterase 5 inhibitors shows insufficient effectiveness in the treatment of post-prostatectomy … Continue reading →